Skip to main content
. 2020 Jul 12;13:2495–2504. doi: 10.2147/DMSO.S260901

Figure 2.

Figure 2

EGCG alleviates endothelial dysfunction of hyperglycemia-induced vascular endothelial cells. (A) The ROS levels in HG-treated HUVECs affected by EGCG was detected by ROS ELISA assay. *P<0.05 and ***P<0.001 vs Normal group. ###P<0.001 vs HG group. P<0.05 and ∆∆∆P<0.001 vs EGCG10μM group. &P<0.05 vs EGCG20μM group. (B) The NO levels in HG-treated HUVECs affected by EGCG was detected by ROS ELISA assay. ***P<0.001 vs Normal group. ##P<0.01 and ###P<0.001 vs HG group. ∆∆∆P<0.001 vs EGCG10μM group. &&P<0.01 vs EGCG20μM group. (C) The expression of p-eNOS and eNOS in HG-treated HUVECs affected by EGCG was detected by Western blot analysis. *P<0.05 and ***P<0.001 vs Normal group. #P<0.05, ##P<0.01 and ###P<0.001 vs HG group. ∆∆∆P<0.001 vs EGCG10μM group. (D) The ROS levels in HG-treated HUVECs affected by EGCG was detected by fluorometric ROS assay.